Omadacycline Enters the Ring: A New Antimicrobial Contender.
- Published in:
- 2019
- Publication type:
- Correction Notice
Works matching IS 02770008 AND DT 2019 AND VI 39 AND IP 2
Results: 11
1
2
Potentially Unsafe Chronic Medication Use Among Older Adult Chronic Opioid Users.
- Published in:
- Pharmacotherapy, 2019, v. 39, n. 2, p. 140, doi. 10.1002/phar.2218
- By:
- Publication type:
- Article
3
Nonaspirin Nonsteroidal Antiinflammatory Drug Use in the Nordic Countries from a Cardiovascular Risk Perspective, 2000–2016: A Drug Utilization Study.
- Published in:
- Pharmacotherapy, 2019, v. 39, n. 2, p. 150, doi. 10.1002/phar.2217
- By:
- Publication type:
- Article
4
ARB Superiority Over ACE Inhibitors in Coronary Heart Disease: An Alternative Viewpoint.
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor
5
Use of a Bioinformatics‐Based Toxicity Scoring System to Assess Serotonin Burden and Predict Population‐Level Adverse Drug Events from Concomitant Serotonergic Drug Therapy.
- Published in:
- Pharmacotherapy, 2019, v. 39, n. 2, p. 171, doi. 10.1002/phar.2215
- By:
- Publication type:
- Article
6
Effects of Atypical Antipsychotic Treatment and Resistant Starch Supplementation on Gut Microbiome Composition in a Cohort of Patients with Bipolar Disorder or Schizophrenia.
- Published in:
- Pharmacotherapy, 2019, v. 39, n. 2, p. 161, doi. 10.1002/phar.2214
- By:
- Publication type:
- Article
7
Influence of Polypharmacy on the Effectiveness and Safety of Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation.
- Published in:
- Pharmacotherapy, 2019, v. 39, n. 2, p. 196, doi. 10.1002/phar.2213
- By:
- Publication type:
- Article
8
Effects of Statin Therapy on the Risk of Intracerebral Hemorrhage in Korean Patients with Hyperlipidemia.
- Published in:
- Pharmacotherapy, 2019, v. 39, n. 2, p. 129, doi. 10.1002/phar.2211
- By:
- Publication type:
- Article
9
Pharmacokinetics and Pharmacodynamics of β‐Lactamase Inhibitors.
- Published in:
- Pharmacotherapy, 2019, v. 39, n. 2, p. 182, doi. 10.1002/phar.2210
- By:
- Publication type:
- Article
10
Cost‐Effectiveness Comparison of Ustekinumab, Infliximab, or Adalimumab for the Treatment of Moderate‐Severe Crohn's Disease in Biologic‐Naïve Patients.
- Published in:
- Pharmacotherapy, 2019, v. 39, n. 2, p. 118, doi. 10.1002/phar.2208
- By:
- Publication type:
- Article
11
Issue Information.
- Published in:
- Pharmacotherapy, 2019, v. 39, n. 2, p. 115, doi. 10.1002/phar.2133
- Publication type:
- Article